Patents by Inventor Melissa Jane Byrne

Melissa Jane Byrne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8292871
    Abstract: A method for treating an occlusion in a coronary artery of a patient includes percutaneously advancing an occlusion treatment tool (such as an angioplasty balloon or stent delivery device) through the vasculature of the patient and into a coronary artery to a site of the occlusion. Following the treatment of the occlusion, a therapeutic agent is admitted into the first coronary artery. The therapeutic agent is selected to treat microvasculature obstructions at a target cardiac tissue site distal to the site of the occlusion.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: October 23, 2012
    Assignee: Osprey Medical, Inc.
    Inventors: James Edward Shapland, Tuan Minh Doan, David Martin Kaye, Adam Lucas Bilney, Melissa Jane Byrne
  • Publication number: 20100274173
    Abstract: A method for treating an occlusion in a coronary artery of a patient includes percutaneously advancing an occlusion treatment tool (such as an angioplasty balloon or stent delivery device) through the vasculature of the patient and into a coronary artery to a site of the occlusion. Following the treatment of the occlusion, a therapeutic agent is admitted into the first coronary artery. The therapeutic agent is selected to treat microvasculature obstructions at a target cardiac tissue site distal to the site of the occlusion.
    Type: Application
    Filed: April 14, 2010
    Publication date: October 28, 2010
    Applicant: Osprey Medical, Inc.
    Inventors: James Edward Shapland, Tuan Minh Doan, David Martin Kaye, Adam Lucas Bilney, Melissa Jane Byrne
  • Patent number: 7722596
    Abstract: A method for treating an occlusion in a coronary artery of a patient includes percutaneously advancing an occlusion treatment tool (such as an angioplasty balloon or stent delivery device) through the vasculature of the patient and into a coronary artery to a site of the occlusion. Following the treatment of the occlusion, a therapeutic agent is admitted into the first coronary artery. The therapeutic agent is selected to treat microvasculature obstructions at a target cardiac tissue site distal to the site of the occlusion.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: May 25, 2010
    Assignee: Osprey Medical, Inc.
    Inventors: James Edward Shapland, Tuan Minh Doan, David Martin Kaye, Adam Lucas Bilney, Melissa Jane Byrne